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Abstract - We present a model of an Artificial Neural Network (ANN) applied to stroke diagnosis. We use input 
data related to stroke that serves as inputs for the ANN. These data include clinical symptoms together with 
stroke risk factors. Each type of data provides input that is evaluated and used during the ANN processing. The 
adaptive learning algorithm can be used with a plethora of types of medical data and integrated into 
categorizedoutputs. 
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I. INTRODUCTION 
 
It is thought that some 15 million people worldwide suffer a stroke yearly. Of those 15 million, approximately 
six million die and a further five million are left with permanently disability. Stroke is believe to be the second 
leading cause of disability, after dementia. Disabilities associated with stroke include loss of vision, speech, 
paralysis, aphasia, dyspahasia and many more. Worldwide, stroke is believed to be the second leading cause of death 
in people above the age of 60 years, and is thought to be the the fifth leading cause of death in the age group 15 to 
59 years. Although stroke occurs less in people under 40 years, people of this age group can suffer stroke. High 
blood pressure is a common cause of stroke, but other causes can include hypercholesterolemia, hyperlipidaemia, 
and smoking.  In the developing world, however, the incidence of stroke is increasing. [1] [16].  In spite of attempts 
to reduce these risk factors in populations the overall rate of stroke remains high due to an increasing aged population 
[2]. 
A stroke otherwise known as a "brain attack", cerebro-vascaular accident or cerebro-vascaular incident, can 
occur at any time. It occurs when blood flow in a vessel in the cerebral vasculature supplying an area of the brain  is 
cut off. When this happens, brain cells supplied by that vessel are deprived of oxygen and begin to die. When brain 
cells die during a stroke, this has a profound effect on the functions that are controlled by that area of the brain e.g. 
memory and control over muscle movement may be severely affected or lost. It is therefore important to diagnose 
stroke in any individual as quickly as possible, such that the patient may be transferred to hospital in 
order to facilitate fast effective treatment. Such treatments include dissolving the blood clot with an anti- 
thrombolytic such as Alteplase or mechanical blood clot removal devices, in the case of strokes caused by clots of 
blood in a vessel supplying the brain. In the case of haemorrhagic stroke, where the blood supply is  cut off due to  
a burst vessel in the brain, a craniotomy may be performed to reduce the inter cranial pressure and/or drugs such as 
mannitol and dexamethasone may be used to decrease the raised inter-cranial pressure. 
 
 
II. BACKGROUND 
 
The extent to which a person suffers disability as a result of their stroke depends on where the stroke occurs in 
the brain and how much of the brain is actually damaged. For example, someone who had a small stroke affecting 
only a relatively small area of the brain may only suffer minor problems e.g weakness of a hand. Patients who suffer 
a major stroke may be left with permanent paralysis on one side of their body or lose their ability to speak. Some 
patients recover completely from strokes, but about 66% of stroke survivors will have some type of disability.[3] 
Artificial neural networks (ANNs) are widely used in science and technology with applications in chemistry, 
physics, and biology [4]. A database is used to produce a clinically relevant output. The input data has "plasticity". 
ANNs have been shown to be useful in the analysis of e.g. blood and urine samples in conditions such as diabetes, 
diagnosis of tuberculosis, and classification of the leukemias [5-9]. 
One style of ANN treats the nodes as 'artificial neurons'. This is the underlying principal of an artificial neural 
network (ANN). An artificial neuron is a computational model based on the natural neurons that occur in the brain. 
Natural neurons in the brain receive signals via synapses situated on the dendrites of the neurons. If the signals 
received reach a certain level (i.e. surpass a certain threshold), and normally this is via an action potential, the neuron 
is activated and emits a signal via the axon. This signal is then sent to another synapse, and would activate other 
neurons etc. 
In this paper, we present the application of an Artificial Neural Network (ANN) model to the diagnosis of stroke 
We will attempt to show the limits of the ANN, and describe the potential future developments of the application of 
ANN's to the field of stroke medicine. 
A neural network is therefore formed by a series of "neurons" (or "nodes") that are organized into many layers. 
Each neuron in one layer is connected with each neuron in the next layer through a weighted connection. The value 
of the weighting wij purports the strength of the connection, i.e. the ith - neuron in a given layer and the jth neuron in 
the next given layer etc [10]. 
Consequently, the structure of an ANN is formed by an "input" layer, one or more "hidden" layers, and the 
"output" layer. The number of neurons in a given layer and the number of layers is dependent on the complexity  
of the system in question. Therefore, an optimal network structure must be ascertained. 
Typically an ANN model has 3 layers and a set of basic rules based on multiplication, summation and activation. 
At the beginning of the system we have artificial neurons- the inputs and these are  weighted.  This means in practice 
that every input value is multiplied with an individual weight. In the middle section of the artificial neuron there is a 
so-called sum function that sums all weighted inputs and biases. At the exit of the artificial neuron network, the sum 
of the previously weighted inputs and biases are passed through a so-called activation function that is also known as 
the transfer function. The basic structure of an ANN is shown in figure 1[10]. By this means data is processed through 
the ANN. 
 
 
Figure 1. The basic structure of an ANN [10] 
For purposes of developing and investigating the application of ANN's to stroke diagnosis, we employ the 
equations below in [10]. Hidden layers contain units that may be regarded as nodes that are situated between the 
input nodes and the output nodes. Hidden units allow the network to use combinations of the input features. However 
one problem that can arise is that if there are too many hidden units, the ANN will then memorize the input patterns 
(so- called overfitting). On the other hand, given too few hidden units, the network may not be able to use all of the 
necessary generalizations (this is called, underfitting). The output of the ANN maybe positive, negative or uncertain 
[10]. 
In the final analysis, the neurons in the last layer provide the network's output. The j-th neuron in a hidden 
layer processes the incoming data by: a) calculating the weighted sum and adding a "biasing" according to 
Equation (1): 
 
 (j=1,2,…n) (1) 
b) transforming the net nj through a suitable mathematical "transfer function", and c) transferring the result to 
neurons  in the next layer. The most commonly used transfer function is the sigmoid one: 
 
                                        (2) 
 
TABLE 1. RISK FACTORS FOR STROKE AND STROKE SYMPTOMS [12][15]. 
 
 Patient Symptom 
1 Acute paraesthesia of arm or leg, (frequently unilateral) 
2 
Acute Confusion, dysphasia or affected cognitive 
function 
3 Vision affected unilaterally or bilaterally 
4 
Acute problems with mobility, vertigo, coordination, or 
balance 
5 Acute severe headache of unknown aetiology 
6 Diabetes 
7 Hypertension 
8 Previous TIA or mini stroke 
9 Carotid artery stenosis (due to atheromatous plaque) 
10 Facialweakness 
11 Smoking 
12 Arm weakness 
13 Speechdisturbances(aphasia) 
14 Hemiparesis or hemisensory aspects affected 
15 Diplopia 
16 Ataxia 
 
 
 
III. THE MODEL 
 
Feed-forward neural networks [11] are used extensively and are successfully used in models involving 
classification, forecasting of various types, and problem solving. Feed-forward back propagation neural networks are 
used in the diagnosis of diseases. They have only one "rule" and that is that information must flow in ne direction 
from input to output with no back-loops. There are however no limitations on the number of layers, the type of 
transfer function used in the individual artificial neurons or the number of connections between the individual 
artificial neurons in the ANN. 
The model applied in this paper is a neural network model with 16 inputs which are a combination of patient 
symptoms and risk factors associated with stroke. The presence of a given symptom and risk factor is depicted by 1 
and absence is depicted by 0. In this model two hidden layers have been used. The output layer consists of one  node 
which represents the probability that stroke will occur. 
The input layer of the neural network is determined by the properties of the application input. To determine the 
probability that stroke will occur, we use 16 inputs which are a combination of symptoms and risks factors, as shown 
in table 1. These input parameters are based on stroke risk factors and symptoms associated with [12] 
We can predict the presence or absent of stroke based   on the output of the ANN. So if the output is 1 stroke is 
present and if it is 0 stroke is absent. The network error function E(t) at the time t is be defined as follows: 
 
                                           (3) 
The weight change on a given layer is given by Equation (4): 
 
                                (4) 
where a is a positive constant called the learning rate. In order to achieve a faster learning rate, and avoid local 
minima, an additional term may be used and Equation 4 then becomes: 
 
            (5) 
Where β is the "momentum" term and the term ∆wij
k-1 in equation (5), is the change of the weight wij from the 
(k- 1)-th learning cycle. The learning rate controls the weighted update rate in accordance with the the new weight 
change. The role of the momentum is to act as a type of stabilizer, in relation to the previous weight change. 
 
 
 
IV. RESULTS AND DISCUSSION 
 
We used the Neural network toolbox in Matlab to evaluate the performance of the stroke diagnosis network. 
We show an example where stroke has been diagnosed using a two-layer feed-forward network with 16 inputs  and 
20 sigmoid hidden neurons together with linear output neurons. The Levenberg-Marquardt back propagation 
algorithm [13] was used to train the network. Training is automatically stopped when generalization ceases to 
improve, as indicated by an increase in the mean square error (MSE) of the validation samples. The network was 
simulated in the testing set. Figure 2 indicates the training state values. The results were very good. The best 
validation performance is 0.0014027 at epoch 12 as shown in Figure.3. The mean squared error (MSE) is the 
average squared difference between outputs and targets. 
 
 
Figure.2.The Training state values 
 
 
Figure 3. The Epochs 
 
 
 
V. CONCLUSIONS 
 
In this paper we have presented an artificial neural network for the medical diagnosis of stroke. This study set out to 
evaluate the performance of the ANN as applied to stroke diagnosis. Our study indicated that the feed-forward back 
propagation neural network with supervised learning may potentially be useful in diagnosing stroke. ANN's are therefore 
potentially useful as an adjunct in helping medical staff to analyze, model, and interpret a plethora of complex clinical data 
related to particular medical applications. The results showed that the proposed ANN could potentially be useful for 
identifying stroke in patients. Artificial neural networks that have the capacity to learn by example, and training, provide 
a very flexible structured tool in medical diagnosis. We feel that our modelling may be further extended by using more 
input data in the ANN. This data could involve including individual patient data and use of stroke scoring systems as 
parameters. It may also be possible to develop the ANN such that it could be used to potentially predict the prognosis of 
an individual stroke patient. That prognosis could then be compared with actual stroke outcome/prognosis for particular 
patients. We also in our second paper (Mirtskhulava et al 2015) consider how ANN's might be applied to the detection and  
diagnosis  of noctural stroke in particular [14]. 
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